First National Advisers LLC Has $689,000 Holdings in Humana Inc. (NYSE:HUM)

First National Advisers LLC cut its holdings in Humana Inc. (NYSE:HUM) by 27.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,715 shares of the insurance provider’s stock after selling 1,048 shares during the period. First National Advisers LLC’s holdings in Humana were worth $689,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of HUM. Harbour Investments Inc. lifted its position in Humana by 48.6% during the third quarter. Harbour Investments Inc. now owns 642 shares of the insurance provider’s stock worth $203,000 after purchasing an additional 210 shares during the period. CIBC Asset Management Inc lifted its position in Humana by 7.7% during the third quarter. CIBC Asset Management Inc now owns 17,755 shares of the insurance provider’s stock worth $5,624,000 after purchasing an additional 1,274 shares during the period. Empowered Funds LLC lifted its position in Humana by 164.0% during the third quarter. Empowered Funds LLC now owns 14,914 shares of the insurance provider’s stock worth $4,724,000 after purchasing an additional 9,264 shares during the period. Natixis Advisors LLC lifted its position in Humana by 1.1% during the third quarter. Natixis Advisors LLC now owns 96,375 shares of the insurance provider’s stock worth $30,526,000 after purchasing an additional 1,023 shares during the period. Finally, Kinsale Capital Group Inc. lifted its position in Humana by 21.2% during the third quarter. Kinsale Capital Group Inc. now owns 11,777 shares of the insurance provider’s stock worth $3,730,000 after purchasing an additional 2,062 shares during the period. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on HUM shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Barclays increased their target price on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Morgan Stanley dropped their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. Piper Sandler increased their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $285.68.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.32% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $253.11 on Monday. The company has a market capitalization of $30.55 billion, a PE ratio of 25.44, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a 50 day simple moving average of $271.37 and a two-hundred day simple moving average of $279.50. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.40%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio (DPR) is 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.